Dean Margeson
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Acute Myeloid Leukemia Research 8
- Chronic Myeloid Leukemia Treatments 4
-
- Epigenetics and DNA Methylation 1
- Histone Deacetylase Inhibitors Research 1
- Co-authors
- Guido Marcucci (9 shared papers)Clara D. Bloomfield (9 shared papers)Kati Maharry (9 shared papers)Susan P. Whitman (8 shared papers)Michael A. Caligiuri (7 shared papers)Sebastian Schwind (6 shared papers)Yue-Zhong Wu (5 shared papers)Krzysztof Mrózek (8 shared papers)
- Partner nations
- United StatesGermany
In The Last Decade
Dean Margeson
9 papers receiving 945 citations
Dean Margeson's Hit Papers
Peers
Comparison fields: 5 of 43
- Hematology 681
- Genetics 242
- Cancer Research 247
- Molecular Biology 485
- Public Health, Environmental and Occupational Health 140
Countries citing papers authored by Dean Margeson
This map shows the geographic impact of Dean Margeson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean Margeson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean Margeson more than expected).
Fields of papers citing papers by Dean Margeson
This network shows the impact of papers produced by Dean Margeson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean Margeson. The network helps show where Dean Margeson may publish in the future.
Co-authors
The 25 scholars most cited alongside Dean Margeson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study Hit paper breakdown → | 2010 | 555 |
| 2 | 2009 | 244 | |
| 3 | 2010 | 77 | |
| 4 | 2008 | 56 | |
| 5 | 2009 | 19 | |
| 6 | 2009 | 4 | |
| 7 | 2009 | 3 | |
| 8 | 2009 | 2 | |
| 9 | 2010 | 1 |
About Dean Margeson
Dean Margeson is a scholar working on Hematology, Molecular Biology, Cancer Research, Genetics and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 961 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (4 papers), Cancer Genomics and Diagnostics (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Acute Lymphoblastic Leukemia research (1 paper), Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper), Epigenetics and DNA Methylation (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Hematology (681 citations), Genetics (242 citations), Cancer Research (247 citations), Molecular Biology (485 citations) and Public Health, Environmental and Occupational Health (140 citations). Dean Margeson has collaborated with scholars based in United States and Germany. Frequent co-authors include Guido Marcucci, Clara D. Bloomfield, Kati Maharry, Susan P. Whitman, Michael A. Caligiuri, Sebastian Schwind, Yue-Zhong Wu, Krzysztof Mrózek, Andrew J. Carroll and Richard A. Larson. Their work appears in journals such as Blood and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.